The Gross Margin of Regeneron Pharmaceuticals Inc (REGN) is 87.01%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 87.01% |
| 2023-12-31 | 86.94% |
| 2022-12-31 | 87.18% |
| 2021-12-31 | 84.83% |
| 2020-12-31 | 86.82% |
| 2019-12-31 | 90.05% |
| 2018-12-31 | 93.53% |
| 2017-12-31 | 93.24% |
| 2016-12-31 | 93.85% |
| 2015-12-31 | 90.42% |